Wilmington, DE -- (SBWIRE) -- 10/07/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Dendreon Corp. (NASDAQ:DNDN) and Osiris Therapeutics, Inc. (NASDAQ:OSIR).
Dendreon Corp. (NASDAQ:DNDN) a biotechnology company that engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients is currently up (+0.06%) on 928,020 shares traded after DENDREON CORP Filed SEC form 8-K, Change in Directors or Principal Officers. Dendreon Corp. (NASDAQ:DNDN) is currently up (+5.2%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Dendreon Corp. (NASDAQ:DNDN)
Osiris Therapeutics, Inc. (NASDAQ:OSIR) a stem cell company that focuses on the development and marketing of therapeutic products to treat medical conditions in the inflammatory, cardiovascular, orthopedic, and wound healing markets is currently down (-5.34%) on 195,992 shares traded. Osiris Therapeutics, Inc. (NASDAQ:OSIR) is currently down (-32.85%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Osiris Therapeutics, Inc. (NASDAQ:OSIR)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)